| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0272-6386(12)80312-X |
| P698 | PubMed publication ID | 1621674 |
| P2093 | author name string | K A Nath | |
| P2860 | cites work | Interferon gamma-mediated renal MHC expression in mercuric chloride-induced glomerulonephritis | Q28326428 |
| Essential fatty acid deficiency ameliorates acute renal dysfunction in the rat after the administration of the aminonucleoside of puromycin | Q28331391 | ||
| Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease | Q33822064 | ||
| Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution | Q34184316 | ||
| Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells | Q34191473 | ||
| Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants | Q34261706 | ||
| Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. | Q34548269 | ||
| Secretory products of macrophages | Q34557411 | ||
| Analysis of renal fibrosis in a rabbit model of crescentic nephritis. | Q34562823 | ||
| Hypokalemic nephropathy in the rat. Role of ammonia in chronic tubular injury | Q34572148 | ||
| Induction of hypertrophy in cultured proximal tubule cells by extracellular NH4Cl | Q34580576 | ||
| Adaptation of Na+-H+ exchange in renal microvillus membrane vesicles. Role of dietary protein and uninephrectomy | Q34621469 | ||
| Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis | Q36219361 | ||
| Tolerance to parenchymal self. Regulatory role of major histocompatibility complex-restricted, OX8+ suppressor T cells specific for autologous renal tubular antigen in experimental interstitial nephritis | Q36351349 | ||
| The progression of renal diseases: On the pathogenesis of renal interstitial fibrosis | Q36834902 | ||
| Cytolysis of nucleated cells by complement: cell death displays multi-hit characteristics | Q37615595 | ||
| Anatomy of the renal interstitium | Q37771581 | ||
| Activation of the inflammatory response of neutrophils by Tamm-Horsfall glycoprotein | Q68718226 | ||
| Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis | Q68790534 | ||
| Leukocyte analysis using monoclonal antibodies in human glomerulonephritis | Q68821323 | ||
| Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents | Q68835829 | ||
| A factor from damaged rat kidney stimulates collagen biosynthesis by mesangial cells | Q68882051 | ||
| Tubulointerstitial disease in lupus nephritis: relationship to immune deposits, interstitial inflammation, glomerular changes, renal function, and prognosis | Q68924689 | ||
| Expression of HLA-DQ, -DR, and -DP antigens in normal kidney and glomerulonephritis | Q69061588 | ||
| Lipid abnormalities and peroxidation of erythrocytes in nephrotic syndrome | Q69410269 | ||
| Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis | Q69430644 | ||
| Ultrastructural changes in renal tubules associated with glomerular bleeding | Q69560839 | ||
| Pathogenesis and therapy of interstitial nephritis | Q69704280 | ||
| Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis | Q70090260 | ||
| Characterization of human renal fibroblasts in health and disease: I. Immunophenotyping of cultured tubular epithelial cells and fibroblasts derived from kidneys with histologically proven interstitial fibrosis | Q70174120 | ||
| Phagocytosis of erythrocytes by the proximal tubule of the rat kidney | Q70475161 | ||
| Glomerular hemodynamics in experimental diabetes mellitus | Q70801958 | ||
| The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings | Q70980087 | ||
| The renal tubulointerstitium in diabetes mellitus | Q37771593 | ||
| Nephritogenic tubulointerstitial antigens | Q37771600 | ||
| Immune recognition and response to the renal interstitium | Q37771601 | ||
| How lymphocytes kill | Q37918816 | ||
| Tamm-Horsfall protein--uromodulin (1950-1990). | Q37937308 | ||
| Functional adaptation to reduction in renal mass | Q37953803 | ||
| MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells | Q38147109 | ||
| Ammonia production and secretion by the proximal tubule | Q38704287 | ||
| Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis | Q38758975 | ||
| Tubular hypermetabolism as a factor in the progression of chronic renal failure | Q39520500 | ||
| Endocytic uptake, transport, and catabolism of proteins by epithelial cells | Q39813510 | ||
| Control of hydrogen ion homeostasis and renal acidosis | Q40003642 | ||
| Effects of nephron reduction and dietary protein content on renal ammoniagenesis in the rat. | Q40338986 | ||
| Effect of reduced renal mass on ammonium handling and net acid formation by the superficial and juxtamedullary nephron of the rat. Evidence for impaired reentrapment rather than decreased production of ammonium in the acidosis of uremia | Q40681958 | ||
| Elevated urinary excretion of the C5b-9 complex in membranous nephropathy | Q41148483 | ||
| Mechanisms of tubulointerstitial fibrosis | Q41156955 | ||
| Lupus nephritis: correlation of interstitial cells with glomerular function | Q41173298 | ||
| Reaction of MDCK cells to crystals of monosodium urate monohydrate and uric acid | Q41223320 | ||
| C5b-8 and C5b-9 modulate the collagen release of human glomerular epithelial cells | Q41230439 | ||
| Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease | Q41533607 | ||
| Abnormal growth and clonal proliferation of fibroblasts derived from kidneys with interstitial fibrosis | Q41718734 | ||
| Detection of nephritogenic antigen from the Lewis rat renal tubular basement membrane | Q42076974 | ||
| Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy | Q42223007 | ||
| Differing regulation and function of ICAM-1 and class II antigens on renal tubular cells | Q42475029 | ||
| Platelet-derived growth factor receptors in the kidney--upregulated expression in inflammation. | Q44162275 | ||
| Production of collagen type I by mouse peritoneal macrophages | Q44480351 | ||
| Effect of leukocyte depletion on the function of the postobstructed kidney in the rat. | Q46118797 | ||
| Induction, characterization, and cell transfer of autoimmune tubulointerstitial nephritis | Q46505913 | ||
| Albuminuria causes lysozymuria in rats with Heymann nephritis | Q46611936 | ||
| Expression of leucocyte and lymphocyte adhesion molecules in the human kidney | Q46781835 | ||
| Rate-limiting factor in rat kidney slice ammoniagenesis. | Q50970554 | ||
| Characterization of human renal fibroblasts in health and disease: II. In vitro growth, differentiation, and collagen synthesis of fibroblasts from kidneys with interstitial fibrosis. | Q52236634 | ||
| Structural-functional correlations in renal disease. II. The correlations. | Q53005548 | ||
| Hydrogen peroxide in tumours; its possible significance in carcinogenesis. | Q53616993 | ||
| Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. | Q54184518 | ||
| Acquired renal cysts in five-sixths nephrectomized rats: the roles of oxalate deposits in renal tubules and a renotropic factor. | Q54393383 | ||
| Renal oxidative metabolism and ammoniagenesis. | Q54463527 | ||
| Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis | Q57741451 | ||
| The Brush Border of Proximal Tubules of Normal Human Kidney Activates the Alternative Pathway of the Complement System In Vitroa | Q58831953 | ||
| Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse | Q67269976 | ||
| Experimental hyperuricemic nephropathy. A model for human urate deposition disease | Q67348690 | ||
| Urinary albumin, transferrin and iron excretion in diabetic patients | Q67804817 | ||
| Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy | Q67804825 | ||
| Measurement of SC5b-9 in urine in patients with the nephrotic syndrome | Q67804910 | ||
| Evidence of an increased susceptibility to lipid peroxidation in red blood cells of chronic renal failure patients | Q67938932 | ||
| Synthesis of type III collagen by cultured kidney epithelial cells | Q67989449 | ||
| Stimulated kidney tubular epithelial cells express membrane associated and secreted TNF alpha | Q68046290 | ||
| Tubulointerstitial nephritis by Tamm-Horsfall glycoprotein or egg white component | Q68214222 | ||
| Effects of probucol on renal function in rats with bilateral ureteral obstruction | Q68642497 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 1-17 | |
| P577 | publication date | 1992-07-01 | |
| P1433 | published in | American Journal of Kidney Diseases | Q4744250 |
| P1476 | title | Tubulointerstitial changes as a major determinant in the progression of renal damage | |
| P478 | volume | 20 |
| Q39360592 | 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor simvastatin ameliorates renal fibrosis through HOXA13-USAG-1 pathway. |
| Q42708993 | A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1. |
| Q48316878 | A Double-blind, Placebo-controlled, Multicenter, Prospective, Randomized Study of Beraprost Sodium Treatment for Cats with Chronic Kidney Disease. |
| Q94207148 | A Preview of Selected Articles |
| Q37078386 | A combined epidemiologic and metabolomic approach improves CKD prediction |
| Q57282418 | A conditionally immortalized Gli1-positive kidney mesenchymal cell line models myofibroblast transition |
| Q33932800 | A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy |
| Q36979205 | A glimpse of various pathogenetic mechanisms of diabetic nephropathy |
| Q45972129 | A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome. |
| Q33728335 | A molecular signature of proteinuria in glomerulonephritis |
| Q57718693 | A nest in renal fibrosis? |
| Q36369955 | A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus |
| Q40752346 | A role for Wnt-4 in renal fibrosis |
| Q50175524 | AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms. |
| Q90340951 | ASK1 contributes to fibrosis and dysfunction in models of kidney disease |
| Q90681133 | Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury |
| Q46681672 | Activation of renal haeme oxygenase-1 alleviates gentamicin-induced acute nephrotoxicity in rats |
| Q34151096 | Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis |
| Q52724019 | Acute Kidney Injury and Progression of Diabetic Kidney Disease. |
| Q38016747 | Acute kidney injury and chronic kidney disease: an integrated clinical syndrome |
| Q48243833 | Acute kidney injury and progression of renal failure after fetal programming in the offspring of diabetic rats |
| Q33840576 | Acute kidney injury: a springboard for progression in chronic kidney disease |
| Q44854978 | Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies |
| Q61648732 | Adrenomedullin inhibits connective tissue growth factor expression, extracellular signal-regulated kinase activation and renal fibrosis |
| Q36593159 | Age sensitizes the kidney to heme protein-induced acute kidney injury |
| Q53049446 | Aggravated renal tubular damage and interstitial fibrosis in mice lacking guanylyl cyclase-A (GC-A), a receptor for atrial and B-type natriuretic peptides. |
| Q34078703 | Akt2 is involved in loss of epithelial cells and renal fibrosis following unilateral ureteral obstruction |
| Q37444731 | Aliskiren: a novel renoprotective agent or simply an alternative to ACE inhibitors? |
| Q37737827 | Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice |
| Q52514733 | Alternative pathway activation of complement by cultured human proximal tubular epithelial cells. |
| Q46317296 | Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice |
| Q35844644 | Amelioration of progressive renal injury by genetic manipulation of Klotho gene |
| Q57025350 | An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis |
| Q37718602 | An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease |
| Q58214943 | Angiotensin II Induces alpha3(IV) Collagen Expression in Cultured Murine Proximal Tubular Cells |
| Q33902166 | Angiotensin II-induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous transforming growth factor-beta |
| Q40711044 | Arterial thrombosis in the context of HCV-associated vascular disease can be prevented by protein C. |
| Q34436358 | Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction |
| Q35646060 | Association between Hemoglobin Concentration and the Progression or Development of Albuminuria in Diabetic Kidney Disease |
| Q92449592 | Association between epidermal growth factor (EGF) and EGF receptor gene polymorphisms and end-stage renal disease and acute renal allograft rejection in a Korean population |
| Q52965953 | Association between renal iron accumulation and renal interstitial fibrosis in a rat model of chronic kidney disease. |
| Q64071126 | Association of Circulating Tissue Inhibitor of Metalloproteinases-1 and Procollagen Type III Aminoterminal Peptide Levels With Incident Heart Failure and Chronic Kidney Disease |
| Q55332093 | Association of Pathological Fibrosis With Renal Survival Using Deep Neural Networks. |
| Q33814882 | Association of urinary injury biomarkers with mortality and cardiovascular events |
| Q90281902 | Associations of Urine Biomarkers with Kidney Function Decline in HIV-Infected and Uninfected Men |
| Q36950546 | Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). |
| Q38023852 | Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. |
| Q92632140 | Autophagy Function and Regulation in Kidney Disease |
| Q46312225 | Autophagy in diabetic kidney disease: regulation, pathological role and therapeutic potential |
| Q26771919 | Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy |
| Q33897354 | Axl tyrosine kinase protects against tubulo-interstitial apoptosis and progression of renal failure in a murine model of chronic kidney disease and hyperphosphataemia |
| Q43238378 | Biomarkers for Chronic Kidney Disease Associated with High Salt Intake |
| Q46188668 | Biomarkers of tubulointerstitial damage and function in type 1 diabetes |
| Q35071275 | Blockade of TSP1-dependent TGF-β activity reduces renal injury and proteinuria in a murine model of diabetic nephropathy |
| Q42556888 | Blocking both type A and B endothelin receptors in the kidney attenuates renal injury and prolongs survival in rats with remnant kidney |
| Q35093071 | Bmi-1 plays a critical role in protection from renal tubulointerstitial injury by maintaining redox balance |
| Q37225434 | C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease |
| Q37146456 | C/EBP-beta modulates transcription of tubulointerstitial nephritis antigen in obstructive uropathy |
| Q36844814 | C5b-9 does not mediate tubulointerstitial injury in experimental acute glomerular disease characterized by selective proteinuria |
| Q33608913 | CD45RO and CD45RA positive cell populations in idiopathic membranous and IgA glomerulopathy |
| Q90057485 | Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis |
| Q40757689 | Cardioreparation and the concept of modulating cardiovascular structure and function |
| Q35203814 | Causes and consequences of proteinuria: the kidney filtration barrier and progressive renal failure |
| Q36200899 | Cellular senescence limits regenerative capacity and allograft survival. |
| Q47319108 | Characterization of proteinuria in primary glomerulonephritides. SDS-PAGE patterns: clinical significance and prognostic value of low molecular weight ("tubular") proteins |
| Q73686591 | Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin |
| Q40636661 | Chronic transplant rejection |
| Q35364638 | Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy |
| Q39504175 | Circulating bone morphogenetic protein-7 and transforming growth factor-β1 are better predictors of renal end points in patients with type 2 diabetes mellitus |
| Q53601221 | Clinical significance of fractional magnesium excretion (FEMg) as a predictor of interstitial nephropathy and its correlation with conventional parameters. |
| Q46199959 | Clinicopathological features and prognosis of membranoproliferative-like Henoch-Schönlein purpura nephritis in children |
| Q43123671 | Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. |
| Q47238226 | Complement C5a inhibition moderates lipid metabolism and reduces tubulointerstitial fibrosis in diabetic nephropathy. |
| Q33520113 | Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway |
| Q43568340 | Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis |
| Q39676693 | Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. |
| Q39180690 | Could MRI Be Used To Image Kidney Fibrosis? A Review of Recent Advances and Remaining Barriers |
| Q27333630 | Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism |
| Q41991255 | Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes |
| Q77798502 | Current role of renal biopsy in patients with SLE |
| Q50999594 | DNA hypermethylation of sFRP5 contributes to indoxyl sulfate-induced renal fibrosis. |
| Q92106295 | Dapagliflozin Attenuates Renal Tubulointerstitial Fibrosis Associated With Type 1 Diabetes by Regulating STAT1/TGFβ1 Signaling |
| Q94560892 | Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo |
| Q33899411 | Defective CFTR leads to aberrant β-catenin activation and kidney fibrosis. |
| Q28731390 | Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model |
| Q37633937 | Determinants of kidney oxygen consumption and their relationship to tissue oxygen tension in diabetes and hypertension. |
| Q41309643 | Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics |
| Q58774942 | Deubiquitinase inhibitor PR-619 reduces Smad4 expression and suppresses renal fibrosis in mice with unilateral ureteral obstruction |
| Q59619348 | Development of human fetal kidney in obstructive uropathy: Correlations with ultrasonography and urine biochemistry |
| Q50759426 | Diabetes mellitus with normal renal function is associated with anaemia. |
| Q35658612 | Disruption of renal tubular mitochondrial quality control by Myo-inositol oxygenase in diabetic kidney disease |
| Q28508395 | Disruption of the Dapper3 gene aggravates ureteral obstruction-mediated renal fibrosis by amplifying Wnt/β-catenin signaling |
| Q41650221 | Distinct effects of mycophenolate mofetil and cyclophosphamide on renal fibrosis in NZBWF1/J mice. |
| Q84372476 | Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury |
| Q46753406 | Disturbance of lymph circulation develops renal fibrosis in rats with or without contralateral nephrectomy |
| Q38322037 | Downregulation of liver X receptor-alpha in mouse kidney and HK-2 proximal tubular cells by LPS and cytokines |
| Q53658737 | Downregulation of transient receptor potential M6 channels as a cause of hypermagnesiuric hypomagnesemia in obese type 2 diabetic rats. |
| Q36577073 | Drug insight: thiazolidinediones and diabetic nephropathy--relevance to renoprotection |
| Q46823376 | Dual blockade of the rennin-angiotensin system versus maximal recommended dose of angiotensin II receptor blockade in chronic glomerulonephritis |
| Q36207035 | Early Markers of Tubulointerstitial Fibrosis in Children With Idiopathic Nephrotic Syndrome: Preliminary Report. |
| Q40532834 | Early urinary biomarkers for renal tubular damage in spontaneously hypertensive rats on a high salt intake |
| Q48193472 | Early urinary biomarkers of renal tubular damage by a high-salt intake independent of blood pressure in normotensive rats |
| Q92360818 | Effect of linagliptin on oxidative stress markers in patients with type 2 diabetes: a pilot study |
| Q53660961 | Effects of Biejia Ruangan Tablet-containing serum on matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in cultured renal interstitial fibroblasts. |
| Q71284424 | Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts |
| Q73150069 | Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR |
| Q43259006 | Effects of vitamin D3 (cholecalciferol) on adriamycin-induced nephrotoxicity |
| Q40312799 | Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through TGF-beta1 dependent and TGF-beta1 independent pathways. |
| Q35570790 | Elongin C is a mediator of Notch4 activity in human renal tubule cells |
| Q53555810 | Endothelin-1 activates MAPKs and modulates cell cycle proteins in OKP cells. |
| Q37365303 | Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. |
| Q35235683 | Epac1-mediated, high glucose-induced renal proximal tubular cells hypertrophy via the Akt/p21 pathway |
| Q42106829 | Epidermal growth factor as a prognostic biomarker in chronic kidney diseases |
| Q34245363 | Epithelial Notch signaling regulates interstitial fibrosis development in the kidneys of mice and humans |
| Q39242491 | Epithelial to Mesenchymal Transition (EMT) and Endothelial to Mesenchymal Transition (EndMT): Role and Implications in Kidney Fibrosis |
| Q34556186 | Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications |
| Q35189006 | Expression of Notch pathway proteins correlates with albuminuria, glomerulosclerosis, and renal function |
| Q39375111 | Expression of profibrotic genes in a murine remnant kidney model |
| Q71568697 | Expression of transforming growth factor-beta isoforms in human glomerular diseases |
| Q38721838 | Extracellular microRNA signature in chronic kidney disease |
| Q38391570 | Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression |
| Q70966200 | Fibronectin synthesis in tubular epithelial cells: up-regulation of the EDA splice variant by transforming growth factor beta |
| Q42908292 | Fibrosis under arrest |
| Q90702784 | Functional heterogeneity of resident fibroblasts in the kidney |
| Q90114738 | Furosemide stress test and interstitial fibrosis in kidney biopsies in chronic kidney disease |
| Q89276257 | Fuzheng Huayu Formula () prevents rat renal interstitial fibrosis induced by HgCl2 via antioxidative stress and down-regulation of nuclear factor-kappa B activity |
| Q24337097 | GLIPR-2 overexpression in HK-2 cells promotes cell EMT and migration through ERK1/2 activation |
| Q80786402 | GLUT2 protein at the rat proximal tubule brush border membrane correlates with protein kinase C (PKC)-betal and plasma glucose concentration |
| Q37724958 | Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in patients with chronic kidney disease |
| Q77774901 | Gene expression of 5-lipoxygenase and LTA4 hydrolase in renal tissue of nephrotic syndrome patients |
| Q90716283 | Genetic deficiency or pharmacological inhibition of miR-33 protects from kidney fibrosis |
| Q56922011 | Genetic susceptibility to PolyI:C-induced IFNα/β-dependent accelerated disease in lupus-prone mice |
| Q48511280 | Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. |
| Q37361235 | Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury |
| Q46724437 | Glomerular proteinuria induces heme oxygenase-1 gene expression within renal epithelial cells |
| Q90067924 | Growth hormone induces Notch1 signaling in podocytes and contributes to proteinuria in diabetic nephropathy |
| Q24322029 | Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells |
| Q40674196 | Heme: a novel inducer of MCP-1 through HO-dependent and HO-independent mechanisms |
| Q37375446 | Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice |
| Q36022683 | Hepatocyte Nuclear Factor-1β Induces Redifferentiation of Dedifferentiated Tubular Epithelial Cells |
| Q38716178 | High Glucose-Induced Hypomethylation Promotes Binding of Sp-1 to Myo-Inositol Oxygenase: Implication in the Pathobiology of Diabetic Tubulopathy |
| Q55443247 | High-Salt Intake Ameliorates Hyperglycemia and Insulin Resistance in WBN/Kob-Leprfa/fa Rats: A New Model of Type 2 Diabetes Mellitus. |
| Q47139383 | Human induced pluripotent stem cell-derived mesenchymal stem cells prevent adriamycin nephropathy in mice |
| Q45073509 | Hypoxia inducible factor-1α mediates the profibrotic effect of albumin in renal tubular cells |
| Q33399420 | Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease |
| Q34790437 | IL-15, a survival factor for kidney epithelial cells, counteracts apoptosis and inflammation during nephritis |
| Q35845313 | Identifying chemokines as therapeutic targets in renal disease: lessons from antagonist studies and knockout mice. |
| Q73421733 | IgA nephropathy databank: development of a system for management of renal biopsy acquired data |
| Q34666924 | Immunoglobulin light chains activate nuclear factor-κB in renal epithelial cells through a Src-dependent mechanism |
| Q38176819 | Immunopathology of lupus nephritis |
| Q87634342 | In patients with type 1 diabetes simultaneous pancreas and kidney transplantation preserves long-term kidney graft ultrastructure and function better than transplantation of kidney alone |
| Q34795075 | In vivo bradykinin B2 receptor activation reduces renal fibrosis |
| Q85207230 | Increased chemokine excretion in patients suffering from chronic kidney disease |
| Q71009109 | Increased glomerular and interstitial LFA-1 expression in proteinuric immunoglobulin A nephropathy |
| Q40815750 | Increased nephron oxygen consumption: potential role in progression of chronic renal disease |
| Q27315694 | Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis |
| Q41022591 | Inflammation and Progression of CKD: The CRIC Study |
| Q37350777 | Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease |
| Q43542891 | Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats |
| Q38829813 | Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression |
| Q35167862 | Intermediate volume on computed tomography imaging defines a fibrotic compartment that predicts glomerular filtration rate decline in autosomal dominant polycystic kidney disease patients |
| Q50434158 | Introduction: hearing footsteps of the future. |
| Q33283211 | Involvement of renal tubular Toll-like receptor 9 in the development of tubulointerstitial injury in systemic lupus |
| Q37829386 | Is cellular senescence important in pediatric kidney disease? |
| Q41724338 | Is membranous nephropathy only a glomerular disease? |
| Q80502273 | Is sirolimus a nephrotoxic drug? A report of five cases |
| Q42446201 | Isolation of proximal and distal tubule cells from human kidney by immunomagnetic separation. Technical note |
| Q36314902 | JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis |
| Q58723519 | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming |
| Q42820062 | Keishibukuryogan reduces renal injury in the early stage of renal failure in the remnant kidney model |
| Q90604273 | Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study |
| Q38838553 | Kidney Injury Molecule-1 Enhances Endocytosis of Albumin in Renal Proximal Tubular Cells |
| Q34566817 | Laser therapy in metabolic syndrome-related kidney injury |
| Q71009102 | Leukocyte analysis of tubulointerstitial nephritis in primary membranoproliferative glomerulonephritis |
| Q33604107 | Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes |
| Q74731323 | Lipid peroxidation in vitamin E-deficient rats submitted to subtotal nephrectomy |
| Q45036984 | Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria |
| Q30433903 | Lupus glomerulonephritis revisited 2004: autoimmunity and end-organ damage. |
| Q92435107 | MYH9-related disorders display heterogeneous kidney involvement and outcome |
| Q30463019 | Magnetic resonance elastography of the kidneys: feasibility and reproducibility in young healthy adults |
| Q38496315 | Mast cells decrease renal fibrosis in unilateral ureteral obstruction |
| Q26781272 | Mechanisms of Kidney Injury in Lupus Nephritis - the Role of Anti-dsDNA Antibodies |
| Q92914442 | Mechanisms of haemolysis-induced kidney injury |
| Q40815766 | Mechanisms of progressive renal disease in glomerulonephritis |
| Q37221965 | Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis |
| Q82352138 | Membranoproliferative pattern of glomerular injury associated with complement component 9 deficiency due to Arg95Stop mutation |
| Q35124912 | Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. |
| Q90130325 | Methionine abrogates the renoprotective effect of a low-protein diet against diabetic kidney disease in obese rats with type 2 diabetes |
| Q93041782 | Micheliolide ameliorates renal fibrosis by suppressing the Mtdh/BMP/MAPK pathway |
| Q91753945 | Microvascular rarefaction and hypertension in the impaired recovery and progression of kidney disease following AKI in preexisting CKD states |
| Q33701556 | Modulation of angiotensin II-induced inflammatory cytokines by the Epac1-Rap1A-NHE3 pathway: implications in renal tubular pathobiology |
| Q34212843 | Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience. |
| Q35759059 | Molecular Markers of Tubulointerstitial Fibrosis and Tubular Cell Damage in Patients with Chronic Kidney Disease |
| Q27003963 | Molecular mechanisms of diabetic kidney disease |
| Q38062404 | Molecular targets for treatment of kidney fibrosis |
| Q35005731 | Monosodium glutamate (MSG) consumption is associated with urolithiasis and urinary tract obstruction in rats |
| Q56927435 | Multiparametric magnetic resonance imaging of experimental chronic kidney disease: A quantitative correlation study with histology |
| Q46168062 | Myofibroblast and alpha 1 (III) collagen expression in experimental tubulointerstitial nephritis |
| Q27008887 | N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes |
| Q46935653 | NK cells do not mediate renal injury in murine adriamycin nephropathy |
| Q38285618 | Nephrosclerosis: update on a centenarian |
| Q38553929 | New developments concerning the proximal tubule in diabetic nephropathy: in vitro models and mechanisms. |
| Q46598157 | New rat model induced by anti-glomerular basement membrane antibody shows severe glomerular adhesion in early stage and quickly progresses to end-stage renal failure |
| Q52765991 | Notch signaling in the collecting duct regulates renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction in mice. |
| Q42932026 | Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions |
| Q33825369 | Omega-3 and renal function in older adults |
| Q39816079 | Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen |
| Q72378616 | Osteopontin expression in angiotensin II-induced tubulointerstitial nephritis |
| Q42150912 | Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy |
| Q35682855 | Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. |
| Q38966233 | Oxidative stress-induced alterations in PPAR-γ and associated mitochondrial destabilization contribute to kidney cell apoptosis |
| Q37734334 | PGC1α Activators Mitigate Diabetic Tubulopathy by Improving Mitochondrial Dynamics and Quality Control. |
| Q41676132 | PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis |
| Q33552194 | PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells |
| Q35994534 | PTEN loss defines a TGF-β-induced tubule phenotype of failed differentiation and JNK signaling during renal fibrosis |
| Q43996077 | Participation of different macrophage populations and myofibroblastic cells in chronically developed renal interstitial fibrosis after cisplatin-induced renal injury in rats |
| Q33917811 | Pathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis |
| Q42048902 | Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis |
| Q37705263 | Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies |
| Q47709386 | Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: is there cause for alarm? |
| Q89243186 | Pericytes in the renal vasculature: roles in health and disease |
| Q35465168 | Periostin as a tissue and urinary biomarker of renal injury in type 2 diabetes mellitus |
| Q41447730 | Periostin-binding DNA aptamer treatment attenuates renal fibrosis under diabetic conditions |
| Q33579577 | Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass. |
| Q36677363 | Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis |
| Q88593618 | Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker |
| Q42522029 | Pexicrine effects of basement membrane components on paracrine signaling by renal tubular cells |
| Q43969708 | Phenotypic changes and cell cycle activation in early tubulointerstitial injury of rat adriamycin nephrosis |
| Q36753326 | Phenotypic transitions and fibrosis in diabetic nephropathy |
| Q35773580 | Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis. |
| Q35019442 | Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring |
| Q64253047 | Prediction of Drug Positioning for Quan-Du-Zhong Capsules Against Hypertensive Nephropathy Based on the Robustness of Disease Network |
| Q36167999 | Pristane-Accelerated Autoimmune Disease in (SWR X NZB) F1 Mice Leads to Prominent Tubulointerstitial Inflammation and Human Lupus Nephritis-Like Fibrosis |
| Q72403182 | Proceedings of the American Society of Pediatric Nephrology 1993 Education Symposium, Washington, D.C., 4 May, 1993 |
| Q57803709 | Profibrotic effects of angiotensin II and transforming growth factor beta on feline kidney epithelial cells |
| Q40506590 | Prognosis in systemic lupus erythematosus |
| Q39464387 | Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis |
| Q33787746 | Progression of chronic renal disease in the dog. |
| Q41667549 | Progression of renal damage in human glomerulonephritides: is there sleight of hand in winning the game? |
| Q44265323 | Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade |
| Q38775811 | Protein DJ-1 and its anti-oxidative stress function play an important role in renal cell mediated response to profibrotic agents. |
| Q41280800 | Protein kinase B/Akt activity is involved in renal TGF-beta1-driven epithelial-mesenchymal transition in vitro and in vivo |
| Q42784841 | Proteomic analysis of human proximal tubular cells exposed to high glucose concentrations |
| Q52680882 | Proximal Tubular Secretory Clearance: A Neglected Partner of Kidney Function. |
| Q89964386 | Puerarin Attenuates Diabetic Nephropathy by Promoting Autophagy in Podocytes |
| Q33691222 | Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling |
| Q36104887 | Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. |
| Q39303904 | Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis |
| Q60927232 | Recent advances in renal imaging |
| Q33806541 | Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis. |
| Q40003255 | Recombinant N-Terminal Slit2 Inhibits TGF-β-Induced Fibroblast Activation and Renal Fibrosis |
| Q33271012 | Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss. |
| Q73961023 | Reduction of insulin and triglycerides delays glomerulosclerosis in obese Zucker rats |
| Q91707078 | Refining the Mouse Subtotal Nephrectomy in Male 129S2/SV Mice for Consistent Modeling of Progressive Kidney Disease With Renal Inflammation and Cardiac Dysfunction |
| Q40813544 | Regulating factors of renal tubular hypertrophy |
| Q82735153 | Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients |
| Q92702775 | Renal Consequences of Gestational Diabetes Mellitus in Term Neonates: A Multidisciplinary Approach to the DOHaD Perspective in the Prevention and Early Recognition of Neonates of GDM Mothers at Risk of Hypertension and Chronic Renal Diseases in Late |
| Q41494937 | Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts |
| Q36698253 | Renal ageing |
| Q34457886 | Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease |
| Q27021975 | Renal fibrosis in feline chronic kidney disease: known mediators and mechanisms of injury |
| Q50097164 | Renal fibrosis: Primacy of the proximal tubule. |
| Q35746896 | Renal fibrosis: collagen composition and assembly regulates epithelial-mesenchymal transdifferentiation |
| Q38181476 | Renal interstitial fibrosis and Angiotensin inhibition |
| Q38003572 | Renal interstitial hyaluronan: functional aspects during normal and pathological conditions. |
| Q82715862 | Renal protective effects of aliskiren beyond its antihypertensive property in a mouse model of progressive fibrosis |
| Q64237620 | Renal shear wave elastography and urinary procollagen type III amino-terminal propeptide (uPIIINP) in feline chronic kidney disease |
| Q40232940 | Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease |
| Q40995376 | Reshaping the interstitium by platelet-derived growth factor. Implications for progressive renal disease. |
| Q51638670 | Resistive index predicts renal prognosis in chronic kidney disease: results of a 4-year follow-up. |
| Q87327833 | Response of urinary liver-type fatty acid-binding protein to contrast media administration has a potential to predict one-year renal outcome in patients with ischemic heart disease |
| Q79888640 | Restricted intake of dietary advanced glycation end products retards renal progression in the remnant kidney model |
| Q38317847 | Ring-Sp1 decoy oligonucleotide effectively suppresses extracellular matrix gene expression and fibrosis of rat kidney induced by unilateral ureteral obstruction |
| Q26768585 | Role of Bone Marrow-Derived Fibroblasts in Renal Fibrosis |
| Q38042110 | Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease |
| Q37959379 | Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects |
| Q40444286 | Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy |
| Q37510401 | Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension |
| Q28379067 | Role of complement in acute tubulointerstitial injury of rats with aminonucleoside nephrosis |
| Q43174142 | Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy |
| Q40810538 | Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction |
| Q54479244 | Role of non-HLA genetic variants in end-stage renal disease. |
| Q39251967 | SOCS-3 is downregulated in progressive CKD patients and regulates proliferation in human renal proximal tubule cells in a STAT1/3 independent manner |
| Q44901266 | Secretion of collagen type IV by human renal fibroblasts is increased by high glucose via a TGF-beta-independent pathway |
| Q73683748 | Selective antagonism of the AT1 receptor inhibits angiotensin II stimulated DNA and protein synthesis in primary cultures of human proximal tubular cells |
| Q34254623 | Serum bicarbonate concentrations and kidney disease progression in community-living elders: the Health, Aging, and Body Composition (Health ABC) Study |
| Q40649478 | Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis |
| Q52841623 | Serum uromodulin-a marker of kidney function and renal parenchymal integrity. |
| Q60956552 | ShenShuai II Recipe Attenuates Apoptosis and Renal Fibrosis in Chronic Kidney Disease by Increasing Renal Blood Flow and Improving Oxygen Consumption |
| Q38350669 | Sickle cell disease: renal manifestations and mechanisms |
| Q73181312 | Significance of mesangial expression of alpha-smooth muscle actin in the progression of IgA nephropathy |
| Q36304756 | Sirtuins and renal diseases: relationship with aging and diabetic nephropathy |
| Q34160971 | Soluble biglycan as a biomarker of inflammatory renal diseases |
| Q53076761 | Soluble klotho as a marker of renal fibrosis and podocyte injuries in human kidneys. |
| Q38731775 | Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells |
| Q73321126 | Stenosis of the tubular neck: a possible mechanism for progressive renal failure |
| Q73504532 | Stenotic glomerulotubular necks in radiation nephropathy |
| Q44240129 | Study on the relationship between blood stasis syndrome and clinical pathology in 227 patients with primary glomerular disease |
| Q72473993 | Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis |
| Q54667831 | TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling. |
| Q36908400 | Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy |
| Q47817742 | The IL-4 receptor α has a critical role in bone marrow-derived fibroblast activation and renal fibrosis |
| Q45967786 | The JNK Signaling Pathway in Renal Fibrosis. |
| Q94453152 | The MicroRNA MiR-29c Alleviates Renal Fibrosis via TPM1-Mediated Suppression of the Wnt/β-Catenin Pathway |
| Q28297657 | The Na(+)/glucose cotransporters: from genes to therapy |
| Q36299959 | The Pathogenesis and Therapeutic Implications of Tubulointerstitial Inflammation in Human Lupus Nephritis |
| Q88984435 | The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study |
| Q36245167 | The aging kidney: a review -- part I. |
| Q33831294 | The association between age and nephrosclerosis on renal biopsy among healthy adults |
| Q38224257 | The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis |
| Q36485238 | The complex role of PPARgamma in renal dysfunction in obesity: managing a Janus-faced receptor |
| Q40357523 | The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFbeta1 responses in human proximal-tubule epithelial cells. |
| Q40561968 | The effect of high glucose and PPAR-gamma agonists on PPAR-gamma expression and function in HK-2 cells |
| Q28397401 | The effects of environmental chemicals on renal function |
| Q47833047 | The effects of grape seed on apoptosis-related gene expression and oxidative stress in streptozotocin-induced diabetic rats |
| Q37738159 | The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease. |
| Q36612823 | The expression of cytoskeletal proteins in kidney specimens of children with primary focal segmental glomerulosclerosis |
| Q33995681 | The interaction of LFA-1 on mononuclear cells and ICAM-1 on tubular epithelial cells accelerates TGF-β1-induced renal epithelial-mesenchymal transition |
| Q40597024 | The many masks of focal segmental glomerulosclerosis |
| Q92503838 | The many talents of transforming growth factor-β in the kidney |
| Q42376166 | The proteasome inhibitor bortezomib attenuates renal fibrosis in mice via the suppression of TGF-β1. |
| Q45960411 | The relationship among renal injury, changed activity of renal 1-alpha hydroxylase and bone loss in elderly rats with insulin resistance or Type 2 diabetes mellitus. |
| Q46670531 | The relationship between renal injury and change in vitamin D metabolism in aged rats with insulin resistance or type 2 diabetes mellitus |
| Q39812927 | The role of Sirt1 in renal rejuvenation and resistance to stress |
| Q38233128 | The role of adenosine receptors A2A and A2B signaling in renal fibrosis |
| Q37488989 | The role of angiopoietin-1 in kidney disease |
| Q26851073 | The role of autophagy in the pathogenesis of diabetic nephropathy |
| Q52688968 | The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. |
| Q40184915 | The role played by endocytosis in albumin-induced secretion of TGF-beta1 by proximal tubular epithelial cells |
| Q33492379 | The time-dependence of long-term prediction in lupus nephritis |
| Q43686100 | Thrombospondin-1 short hairpin RNA suppresses tubulointerstitial fibrosis in the kidney of ureteral obstruction by ameliorating peritubular capillary injury |
| Q64921739 | Total Extracts of Abelmoschus manihot L. Attenuates Adriamycin-Induced Renal Tubule Injury via Suppression of ROS-ERK1/2-Mediated NLRP3 Inflammasome Activation. |
| Q73338092 | Transforming growth factor beta 1 and renal injury following subtotal nephrectomy in the rat: role of the renin-angiotensin system |
| Q47816856 | Transforming growth factor-beta in renal disease with glycogen storage disease I. |
| Q38585776 | Transgenic sickle mice are markedly sensitive to renal ischemia-reperfusion injury |
| Q40444278 | Tubulointerstitial damage in glomerular diseases: Its role in the progression of renal damage |
| Q42007739 | Tubulointerstitial disease in glomerulonephritis. Potential role of osteopontin (uropontin). |
| Q35766363 | Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement |
| Q42526002 | Tubulointerstitial responses in the progression of glomerular diseases: albuminuria modulates alpha v beta 5 integrin |
| Q51736584 | Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. |
| Q54262576 | Unique changes in interstitial extracellular matrix composition are associated with rejection and cyclosporine toxicity in human renal allograft biopsies. |
| Q46158716 | Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis |
| Q51758089 | Urinary Biomarkers of Kidney Tubular Damage and Risk of Cardiovascular Disease and Mortality in Elders. |
| Q92791402 | Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease |
| Q91975634 | Urinary Cell Adhesion Molecule 1 Is a Novel Biomarker That Links Tubulointerstitial Damage to Glomerular Filtration Rates in Chronic Kidney Disease |
| Q90723740 | Urinary Epidermal Growth Factor/Creatinine Ratio and Graft Failure in Renal Transplant Recipients: A Prospective Cohort Study |
| Q37164509 | Urinary L-type fatty acid-binding protein can reflect renal tubulointerstitial injury. |
| Q35188531 | Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy |
| Q33693244 | Urinary biomarkers: recommendations of the Joint European/United States Workshop for future research |
| Q52670608 | Urinary clusterin-a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival. |
| Q44471144 | Urinary excretion of complement C3d in patients with renal diseases |
| Q35103241 | Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules |
| Q37162318 | Urinary fatty acid-binding protein 1: an early predictive biomarker of kidney injury. |
| Q87945171 | Urinary neopterin: an immune activation marker in mesangial proliferative glomerulonephritis |
| Q54682142 | Urinary proteins from patients with nephrotic syndrome alters the signalling proteins regulating epithelial-mesenchymal transition. |
| Q46233386 | Urine Anion Gap to Predict Urine Ammonium and Related Outcomes in Kidney Disease |
| Q36104818 | Urine Collagen Fragments and CKD Progression-The Cardiovascular Health Study |
| Q38777914 | Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial |
| Q89947074 | Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD |
| Q40175496 | Wen-pi-tang-Hab-Wu-ling-san, an oriental herbal prescription, attenuates epithelial-mesenchymal transdifferentiation stimulated by TGF-beta1 in kidney cells |
| Q33737756 | miR-200b precursor can ameliorate renal tubulointerstitial fibrosis |
| Q34305490 | p66Shc mediates high-glucose and angiotensin II-induced oxidative stress renal tubular injury via mitochondrial-dependent apoptotic pathway |
| Q42905735 | siRNAs targeted to Smad4 prevent renal fibrosis in vivo |
Search more.